Sites of metastases before systemic treatment influence progression patterns and survival in stage IV melanoma patients
{{output}}
Background: Metastatic sites influence response rates to immune checkpoint inhibitors (ICI) and survival, suggesting anatomical locations impact treatment outcomes. This study examines how baseline metastatic sites affect progres... ...
